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Liver  fluke  infection  caused  by Opisthorchis  viverrini  is  a major  public  health  problem  in  Thailand  and
the  Lao  People’s  Democratic  Republic  (Lao  PDR;  Laos).  Currently,  more  than  600  million  people  are  at
risk of  infection  with  these  fish-borne  trematodes  and/or  their  close  relatives.  Opisthorchiasis  has  been
studied  extensively  in  Thailand,  where  about  8  million  people  are  infected  with  the  liver  fluke. Here
we  review  the  pathogenesis,  control  and  re-emergence  of  O.  viverrini  infection,  in  particular  in  Thailand
and, to  a  lesser  extent  in  Lao  PDR  given  the  contiguous  geographical  range  of  O. viverrini  through  these
two  regions.  We  also  review  the  association  of  O.  viverrini  infection  and  cholangiocarcinoma,  bile ductholangiocarcinoma
iver fluke
iver cancer
ood-borne trematodiases
nthelmintic
raziquantel
cancer,  and  highlight  new  findings  on pathogenesis  of  liver  fluke-induced  cholangiocarcinogenesis.  Last,
we comment  on  national  control  strategies  in  Thailand  for the  control  of  O.  viverrini  infection  aimed  at
reduction  in  the  prevalence  of  O.  viverrini-associated  liver  cancer  in the  longer  term.
© 2010 Elsevier B.V. All rights reserved.epatobiliary disease
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. Opisthorchiasis is a neglected tropical disease
The neglected tropical diseases (NTDs) represent the most com-
on  parasitic infections affecting the world’s poorest people (Hotez
t al., 2007). In addition to their detrimental effects on the health,
TDs have a chronic debilitating effect by undermining the physical
nd cognitive development of individuals resident in areas endemic
or NTDs, especially children and women of child bearing age. An
specially deleterious effect has been shown on their educational
erformance and future economic productivity (Hotez et al., 2007,
009). Hence, the NTDs are thought to contribute greatly to keep-
ng the poor impoverished. Over the last 2 years, the major NTDs
ave been ranked according to their global prevalence (Hotez et al.,
007) and their disease burden, as measured in Disability Adjusted
ife Years (DALYs) (Hotez et al., 2009). However, the impacts of
esser known NTDs have been overlooked; these include with liver
uke infection in East and Southeast Asia. New data from East
sia indicate that the disease burden brought about by infection
ith fish-borne liver flukes, Opisthorchis viverrini and the closely
elated Clonorchis sinensis, rivals the disease burden of the seven
ost common NTDs in their impact on this region (see Andrews et
l., 2008; Shin et al., 2010). Indeed, it may  be that because of the
ntense regional nature of the disease burden of this NTD, a region
arked by sub-optimal or poor infrastructure and poverty, the true
xtent of the burden of disease of opisthorchiasis is considerably
nderestimated.
. Life cycle of O. viverrini
The definitive hosts of O. viverrini are humans and other pis-
ivorous mammals. The eggs, shed by adult worms, are deposited
n the biliary tree of the infected person, enter the intestine,
nd are passed with the feces. On reaching water, the eggs are
ngested by snails. Several species of the prosobranch gastropod
enus Bithynia serve as the first intermediate host. Within the snail,
he eggs metamorphose into sporocysts which reproduce asexu-
lly for 4–5 weeks, after which cercariae are shed into the water.
hese free-swimming forms penetrate the skin between the scales
f freshwater fish. Numerous species of freshwater fish, mostly
yprinoids, serve as the second intermediate host (Fig. 1). After
 few days in the fish muscle, cercariae encyst as metacercariae.
umans acquire the infection by ingesting raw or inadequately
ooked infected fish. Influenced by digestive processes in the stom-
ch and intestines, the metacercariae excyst in the duodenum and
igrate though the ampulla of Vater into the bile duct, where they
ature into adult worms over a period of a month. The adult fluke
nhabits the biliary tract, generally localizing within the intrahep-
tic bile ducts. In humans, the adult fluke can survive for more than
0 years, which explains the persistent infection of long duration.
ocations of endemic infection reflect the geographic distribution
f the essential intermediate host snails (Sripa and Pairojkul, 2008).
The closely related liver flukes Opisthorchis felineus and C. sinen-
is have similar life cycles. Opisthorchiasis and clonorchiasis are
revalent in geographical regions where raw cyprinid fish (O. viver-
ini, O. felineus and C. sinensis) and/or shrimp (C. sinensis) are dietary
taples. All three flukes establish in the bile ducts of the liver as well . . . .  .  .  .  .  .  . . . .  .  .  .  .  .  . . .  . .  .  .  .  . . . . . .  .  .  .  . . . . . . .  .  .  . . . . . .  .  . .  . .  .  .  . .  .  .  . .  . . . .  . .  .  .  . . S166
as extrahepatic ducts and the gall bladder of infected persons (Sripa
et al., 2010).
3. Geographical distribution, prevalence and public health
impact of opisthorchiasis
3.1. Geographical distribution of O. viverrini and relatives
The geographical distribution of opisthorchiasis is constrained
by the presence of the requisite intermediate host snails and the
second intermediate host fishes, and dietary preferences of local
populations for uncooked or undercooked fish. O. viverrini infection
is prevalent in Thailand and the Lao People’s Democratic Republic
(PDR), and also occurs in Cambodia and Vietnam. There is a marked
geographical heterogeneity in the prevalence of O. viverrini infec-
tion among the four regions of Thailand; nowadays the highest
prevalence occurs in the North and Northeast (below). In 1981, the
Thailand nationwide prevalence of O. viverrini infection was  14%,
but prevalence varied greatly by region – North (5.59%), North-
east (34.60%), Central (6.34%) and South (0.01%) (Harinasuta and
Harinasuta, 1984). After intensive and continuous control activ-
ities over the subsequent two  decades, prevalence had declined
to 15.7% in the Northeast, leading to a corresponding decline
in the national prevalence to 9.4% in 2001 (Jongsuksuntigul and
Imsomboon, 2003).
At least 10 million people in Thailand and the Lao PDR remain
infected with O. viverrini, with 80% of the Thai cases occurring in
northern and northeastern Thailand. An unknown number of addi-
tional cases also occur in Cambodia and Vietnam (Shin et al., 2010).
In the Lao PDR, O. viverrini infection occurs mainly in southern and
central regions adjacent (i.e. on the opposite side of the Mekong
River) to the endemic regions in northeastern Thailand (Parkin,
2006). Based on a nationwide survey of ∼30,000 primary school
children, in 17 provinces and the Municipality of Vientiane, the
prevalence of O. viverrini infection the Lao PDR was  estimated at
10.9%. Laotian provinces along the Mekong River including Kham-
muane, Saravane or Savannakhet showed even higher prevalence
– 32.2, 21.5, and 25.9%, respectively (Rim et al., 2003). A recent sur-
vey in the southern province of Champasak revealed a prevalence
of O. viverrini infection of 58.5%, among 814 persons sampled from
13 villages (Sayasone et al., 2007).
C. sinensis infection is common in rural areas of northern Viet-
nam, Korea, China and the Russian Far East. O. felineus occurs in
Russia, some republics of the former USSR, Kazakhstan and nearby
countries, and has been recorded recently in Germany, Greece and
Italy (Lun et al., 2005; Keiser and Utzinger, 2005; Armignacco et al.,
2008; Shekhovtsov et al., 2009; Shin et al., 2010). In China, the liver
fluke C. sinensis was  recently estimated by the Chinese Center for
Disease Control to infect 12.5 million people (Ministry of Health,
2005) (Table 1).
Elevated prevalence of O. viverrini infection in the North and
Northeast of Thailand and in the Lao PDR results from the per-
vasive habit by local people of eating raw or undercooked (wild
caught) cyprinoid fish and fish-based dishes (Fig. 1). The fish are
the second intermediate host of O. viverrini and natural popula-
tions of these fishes can be widely and heavily infected (Harinasuta
S160 B. Sripa et al. / Acta Tropica 120S (2011) S158– S168
Fig. 1. Montage of images relating to transmission of Opisthorchis viverrini infection in Khon Kaen Province, Thailand. (Panel A) Bithynia species nails, the intermediate
host  of O. viverrini; Chonnabot District, Khon Kaen Province, Thailand. (Panel B) A fisherman in Chonnabot District, Khon Kaen Province, Thailand. (Panel C) Cyprinoid fish,
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Tbout  10 cm in length, caught in natural water courses in Chonnabot District, Khon
late  of koi-pla, a traditional, widely consumed dish prepared from uncooked cypr
ontaminated with viable, infectious metacercariae of O. viverrini.
nd Harinasuta, 1984; Sithithaworn et al., 1997; Sayasone et al.,
007). The current therapy for opisthorchiasis is oral treatment
ith the anti-trematode drug, praziquantel. Despite widespread
hemotherapy with praziquantel undertaken in the past, the
revalence of O. viverrini still approaches 70% in some districts
amphurs) (Sripa and Pairojkul, 2008; Sripa, unpublished). Like
any neglected infections, opisthorchiasis is chronic and affects
eople for decades, with an insidious onset of disabling health
ffects and even death. Indeed, among the helminth parasitic infec-
ions none can rival the high mortality levels of opisthorchiasis
Bouvard et al., 2009; Shin et al., 2010).
.2. Infection with O. viverrini – public health overview
Although the association between Opisthorchis and Clonorchis
nfections and bile duct cancer has been known for >50 years,
nd notwithstanding the long history of public health interac-
ions in Thailand focused on this problem (below), there remains
 disconcertingly high incidence of O. viverrini-associated cholan-
iocarcinoma in northeastern Thailand (Sripa et al., 2007), and
able 1
he disease burden of human Opisthorchis viverrini and Clonorchis sinensis infection and t
Country Disease Estimated
Infected 
Thailand Opisthorchiasis 8 million 
Lao  PDR Opisthorchiasis 2 million 
Cambodia Opisthorchiasis ND 
Vietnam Clonorchiasis ND 
China Clonorchiasis 12.5 millio
Korea Clonorchiasis ND 
a Probable underestimates. ND, not determined. CCA, cholangiocarcinoma.Province, Thailand (http://en.wikipedia.org/wiki/Amphoe Chonnabot). (Panel D) A
fish (as shown in Panel C), salad vegetables and condiments. Koi-pla is frequently
likely also in adjacent provinces of the Lao PDR (Shin et al., 2010)
(Table 1). Traditional dishes such as koi-pla and pla-som, prepared
from freshwater cyprinoid fish, are the usual source of O. viverrini
infection in northeastern Thailand and the Lao PDR. It has proven
difficult to dissuade at risk populations from the risky behavior of
consuming these dishes, including modifying preparation of the
dishes by heating the constituent fish flesh sufficiently to kill the
metacercariae (Sithithaworn and Haswell-Elkins, 2003; Andrews
et al., 2008; Sripa and Pairojkul, 2008; Shin et al., 2010). Progress
on this front, in tandem with improvements in reticulated sewage
systems to block transmission from human feces to the Bithynia
snails, and education of at risk populations of the dangers of inges-
tion of undercooked fish dishes, and/or to cook the fish, should
eventually lower the incidence of liver fluke-induced liver can-
cer. Biomarkers of incipient cholangiocarcinoma are needed given
that by the time diagnosis of cholangiocarcinoma, in a resource
challenged setting such as the Mekong River provinces of Thailand
and the Lao PDR, prognosis is almost universally poor. Encourag-
ingly, inflammatory biomarkers such as urinary 8oxodG reported
in opisthorchiasis and Opisthorchis-associated cholangiocarcinoma
heir most severe sequela, cholangiocarcinoma.
 numbers References
CCA
5000 Parkin (2006)
>100a Andrews et al. (2008)
ND
>100a Shin et al. (2010)
n 800a Lun et al. (2005)
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re potentially useful for diagnosis, surveillance and control (see
ndrews et al., 2008).
Meantime, the prevalence of infection occurs early in life,
lateaus after the teens, and declines in old age. A small minority
f the population harbors most of the worms while most peo-
le are lightly or not infected. In sites of heavy transmission of
. viverrini, high incidence and rapid re-infection after treatment
ith praziquantel are common. In northeastern Thailand, trans-
ission to humans from the infected fish is seasonal, peaking in the
ooler months when fish exhibit their highest burden of metacer-
ariae. Although infection frequently is sub-clinical, hepatobiliary
isease frequently is seen in residents of O. viverrini endemic
egions. Whereas the hepatobiliary changes usually reverse after
raziquantel chemotherapy, resolution of hepatobiliary disease
oes not occur in all persons after the flukes have been elimi-
ated. Problematically, these individuals may  be at increased risk
f cholangiocarcinoma (Sripa et al., 2009). In any event, upon par-
sitological diagnosis of liver fluke infection (below) immediate
reatment with praziquantel is indicated to eliminate these long-
ived, carcinogenic parasites.
. Diagnosis of opisthorchiasis
.1. Parasitological (faecal) diagnosis
Demonstration of eggs in feces, bile, or duodenal fluid or the
ecovery of flukes during transhepatic stent implantation or from
he liver post mortem is considered the “gold standard” for diag-
osis O. viverrini (Sithithaworn et al., 1991). Faecal examination
s the routine method for diagnosing O. viverrini infection due to
ase, non-invasiveness and cost; techniques include the formalin-
ther concentration technique (FECT), the modified quick Kato Katz
hick smear, and Stoll’s dilution egg count technique (Viyanant et
l., 1983; Elkins et al., 1990; Hong et al., 2003). Sensitivity and speci-
city varies by the method of examination and experience of the
icroscopist. The diagnostic value of these methods lies in the abil-
ty to detect light infections, e.g. an individual treated recently with
raziquantel. Repeated examinations are needed to improve diag-
ostic sensitivity of faecal exams. However, even with repeated
tool examination using a standardized method like FECT, there
an remain discrepancy between egg count and worm detection,
.e. sufficient probability of a false negative diagnosis. In an autopsy
tudy (Sithithaworn et al., 1991), adult O. viverrini were directly
ecovered from 139 livers (the gold standard); fecal examinations
f these same individuals determined that only 67% were positive
or O. viverrini infection. Conventional stool examination methods
ay  underestimate prevalence by ∼20% (Sithithaworn et al., 1991).
Diagnostic specificity of faecal exams can be problematic. Under
ight microscopy, the eggs of O. viverrini are characterized by
ough and thick egg shells, and are similar to several species of
ood-borne trematodes belonging to the families Opisthorchiidae,
eterophyidae and Lecithodendriidae endemic in the same areas.
n Thailand and Laos, the latter two families of trematodes are col-
ectively referred to as minute intestinal flukes (MIFs), because of
heir small size compared to O. viverrini (Kaewkes et al., 1991).
he Lecithodendriidae include Phaneropsolus bonnei and Prosto-
endrium molenkampi while the Heterophyidae include Haplorchis
aichui, Haplorchis pumilio and Stellanchasmus falcatus (Radomyos
t al., 1984; Radomyos et al., 1994). Within the heterophyids,
etagonimus spp. and Heterophyes spp., Haplorchis spp. and Pygid-
opsis spp. occur in Laos and Korea (Chai et al., 2005). The marked
orphological resemblance of MIF  eggs with those of O. viverrini
ncreases the probability of a false positive diagnosis, with con-
omitant decrease in diagnostic specificity (Fig. 2). In areas where O.
iverrini coexists with heterophyid flukes including Haplorchis spp.,0S (2011) S158– S168 S161
the term ‘O. viverrini-like egg’ is sometimes used (Chai et al., 2007).
This dilemma reflects the limitation of the fecal exam in which diag-
nosis is based solely on egg morphology; it also highlights the need
for alternative diagnostic methods.
4.2. Serological diagnosis
Serological tests have been developed, with the aim of develop-
ing a diagnostic assay with greater sensitivity and specificity than
fecal exams. These include the intradermal test (IDT), immunoelec-
trophoresis (IEP), indirect haemagglutination assay (IHA), indirect
fluorescent antibody test (IFAT) and indirect enzyme-linked
immunosorbent assay (indirect ELISA) (Wongratanacheewin et al.,
2003). Indirect ELISA is favored for its ease and the increase in
diagnostic sensitivity and specificity obtained with an antibody-
based system. However, serological tests have failed to achieve
superior diagnostic ability, because of the complex composition of
the crude antigen extracts employed. Crude adult somatic extracts
from O. viverrini have been used for IEP and ELISA, both of which
are estimated to have a sensitivity of 76–100% for IgG and lower
sensitivities for IgA [63%] and IgE [74%] (Poopyruchpong et al.,
1990; Wongsaroj et al., 2001). Additionally, excretory secretory
(ES) antigens from adult O. viverrini have been used. An 89 kDa
protein, among the most prominent in the bands in ES antigen of
O. viverrini, has shown immunodiagnostic potential, even though
it cross-reacts with C. sinensis (Sirisinha et al., 1991). Sandwich
ELISA tests have been developed for increased sensitivity and speci-
ficity for O. viverrini infection. Here, monoclonal antibody-based
affinity-purified crude somatic egg antigen shows improved diag-
nostic specificity and sensitivity in the detection of serum antibody
against O. viverrini by immunoblotting (Wongsaroj et al., 2001).
Attempts to produce recombinant antigen for an IgG antibody
detection kit in an ELISA, such as was  tried with the recombinant
O. viverrini egg shell protein (rOVESP), showed increased diagnos-
tic sensitivity and specificity over faecal exams (Ruangsittichai et
al., 2006). A drawback of antibody-based detection methods is the
inability to differentiate past and present infections with O. viver-
rini, due to the long half-life of the antibody response to O. viverrini,
which can persist in the infected and non-infected hosts for years
after cure (Thammapalerd et al., 1988; Ruangsittichai et al., 2006).
Antigen-based detection systems have also proven to be infor-
mative for current infection (Chaicumpa et al., 1991; Sirisinha et al.,
1991, 1995). Monoclonal antibody (mAb)-based systems offer an
increase in diagnostic sensitivity, enough to detect secretory prod-
uct from a few adult worms, even when eggs are not found in the
stool. Recently, mAbs against ES products of O. viverrini, recogniz-
ing antigens of 45–110 kDa, were developed for the ELISA for faecal
antigen (Sithithaworn, unpublished), exhibiting 69% sensitivity and
39% specificity.
4.3. Molecular diagnosis
Molecular genetic studies of O. viverrini have identified genes
encoding various proteins that are stage specific, potential can-
didates in recombinant form for serodiagnosis (Laha et al., 2008;
Suttiprapa et al., 2008). For DNA-based methods, a probe tar-
geting repetitive DNA has been used for the detection of eggs
(Sirisinha et al., 1991). A PCR-based approach based on a pair of
primers complementary to the same target DNA has shown util-
ity for detection of fecal eggs (Wongratanacheewin et al., 2001,
2002). The assay achieved a specificity of 98% and a sensitivity of
100% in moderate to severe infections (infections with stool epg
levels of >1000) but was less sensitive (68%) in light infections
(<200 epg). Application of this method to detect O. viverrini DNA
in stool samples from Laos yielded sensitivity of ∼50% in sam-
ples with egg count >1000 epg, with assay performance possible
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Fig. 2. Photomicrographs of an egg of O. viverrini (Panel A) and eggs from two  microscopic intestinal flukes (MIF), P. bonnei (Panel B) and Prosthodendrium molenkampi
( ese eggs are 27 m × 15 m (O. viverrini), 30 m × 15 m (P. bonnei) and 24 m × 12 m
( ere is an iodophilic body in the miracidium of embryonated MIF  (lecithodendrid) eggs,
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Box 1: Ultrasonography for Advanced Periductal Fibro-
sis in Opisthorchiasis
During chronic O. viverrini infection, the peripheral intrahep-
atic bile ducts become dilated and thickened from fibrotic
deposition, which images in sonograms as echogenic nodules
with an echo-free center (Mairiang et al., 1993, 2006; Sripa and
Kaewkes, 2000).
• Advanced periductal fibrosis (APF) is defined as 2+ echogenic
nodules in more than one segment of the liver.
• Non-persistent APF is defined as 2+ echogenic nodules in
more than one segment of the liver at baseline and no
echogenic nodules 12 months after treatment with prazi-
quantel (PZQ) for O. viverrini infection.
• Persistent APF is defined as 2+ echogenic nodules in 2 or
more segments of the liver at baseline and again 12 months
after treatment with PZQ (Mairiang et al., 1993, 2006).
• We hypothesize that persistent APF is a risk factor for devel-
opment of cholangiocarcinoma (Sripa et al., 2009).Panel C). All three eggs were passed in human feces. The average dimensions of th
Prostodendrium molenkampi) (Kaewkes et al., 1991). When stained with iodine, th
hich  is absent from O. viverrini eggs.
armed by PCR inhibitors in faeces (Stensvold et al., 2006). Assay
mprovements using cetyltrimethylammonium bromide to remove
nhibitors resulted in enhanced sensitivity (Duenngai et al., 2008),
ncluding capacity to detect ∼10 ng of genomic DNA and as few as
hree metacercariae in fish samples (Parvathi et al., 2008). Species-
pecific PCR tests can discriminate among O. viverrini (Ando et al.,
001; Wongratanacheewin et al., 2001) and O. viverrini, C. sinen-
is (Le et al., 2006) and O. felineus (Pauly et al., 2003). These tests
an be expected to play significant roles in the assessment of cure,
e-infection, and characterizing the endemic range of these food-
orne trematodes in East Asia (Touch et al., 2009; Traub et al., 2009).
hese approaches also are applicable to food safety inspection of
sh products (Parvathi et al., 2007, 2008; Thaenkham et al., 2007;
ato et al., 2009).
. Pathobiology and pathogenesis in opisthorchiasis
.1. Periductal fibrosis due to O. viverrini infection
O. viverrini causes chronic inflammation around the biliary tree,
ith severe hyperplasia of the cholangiocytes that line the biliary
ract proximal to the flukes. Metaplasia of the biliary epithelial
ells into mucin-producing cells occurs early during the infection,
s these cells proliferate to produce small gland-like structures in
he mucosa, leading to persistent and excessive mucus in the bile
Glaser et al., 2009). Chronic and persistent O. viverrini infection
lso results in a gradual increase in fibrous tissues in the biliary
ract, which eventually engulfs these proliferating glands (Sripa et
l., 2003). Severity of this periductal fibrosis correlates with the
uration of infection (Elkins et al., 1991, 1996), parasite burden
Haswell-Elkins et al., 1991, 1994; Sripa et al., 2003) and genetic
usceptibility of the host.
The host immune response mediates much of the hepatobil-
ary damage in opisthorchiasis (Glaser et al., 2009). As with other
hronic inflammation, persistent irritants sustain the simultane-
us production of growth factors and fibrogenic cytokines, which
n turn stimulate the deposition of connective tissue that pro-
ressively remodels and destroys normal tissue architecture of
he biliary epithelium, resulting in the accumulation of fibrotic
lements (Wynn, 2007, 2008). In opisthorchiasis, the persistentirritation can derive from several sources (Glaser et al., 2009) –
mechanical irritation, due feeding and migration of flukes as oral
and ventral suckers of flukes hook onto biliary epithelia and dam-
age tissue, and metabolic products released from the tegument
and excretory openings of parasites that come into contact with
the bile duct epithelium. The metabolic products are thought to be
immunogenic, mitogenic, and/or even toxic to the biliary epithe-
lium (Sripa et al., 2007). Notably, the process of fibrotic deposition
during opisthorchiasis differs from the well-known phenomenon
of Schistosoma mansoni liver fibrosis. Advanced periductal fibrosis
(APF) in O. viverrini infection (diagnosable by portable ultrasound
examination) (Sripa et al., 2009) (Box 1 ), is confined to the bile ducts
and not to the liver at large (Sripa et al., 2009). APF from O. viver-
rini does not result from granulomas around fluke eggs, although
fluke eggs are often present in the bile duct and are detected on
ultrasonography (Sripa, 2003). Third, APF is likely mediated by a
pro-inflammatory cytokine network mediated by IL-6 and TNF-,
and not via Th2 cytokines (Sripa, 2003).
B. Sripa et al. / Acta Tropica 120S (2011) S158– S168 S163
Table 2
Top 10 diseases with high mortality in Thai population stratified by sex for the year 2004 (modified from Sripa and Pairojkul, 2008).
Rank Male Female
Disease Deaths (thousands) % % Deaths (thousands) Disease
1 HIV/AIDS 26 11.1 14.7 26 Stroke
2  Stroke 23 10.0 8.0 14 Diabetes
3  Traffic accidents 23 9.9 6.6 12 Ischemic heart disease
4 Liver  and bile duct cancer 19 8.0 6.2 11 HIV/AIDS
5 COPD  14 5.9 4.9 9 Liver and bile duct cancer
6  Ischemic heart disease 13 5.6 3.8 7 Lower respiratory tract infections
7  Bronchus and lung cancer 9 3.7 3.4 6 COPD
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.2. Cholangiocarcinoma
Cholangiocarcinoma (CCA) is a primary cancer originating in
he biliary epithelium, i.e. the cholangiocytes, of the extrahepatic
nd intrahepatic biliary ducts. It is extremely invasive, develops
apidly, often metastasizes, and has a very poor prognosis (Blechacz
nd Gores, 2008). CCA has a worldwide distribution and accounts
or about 10–15% of all cases of primary hepatobiliary malignancy
Parkin et al., 1993; Parkin, 2006; Shin et al., 2010). They are slow
rowing tumors which spread longitudinally along the bile ducts
ith neural, perineural and subepithelial extensions (Parkin et al.,
993; Malhi and Gores, 2006). While in the Western countries,
–10% of cholangiocarcinomas arise from the intrahepatic ducts
nd 90–95% from the extrahepatic ducts, in countries where O.
iverrini is endemic (Thailand, Lao PDR), intrahepatic CCA is 40% and
xtrahepatic 60% of all cases; most of the cases identified in Khon
aen are intrahepatic (Sripa and Pairojkul, 2008). The location at
he upper hepato-duodenal ligament, extension into the liver and
roximity to major blood vessels make early evaluation challeng-
ng. Hence, the prognosis of patients with non-resectable tumors
s poor, and the majority of patients die within a year of diagno-
is. No medical treatment is available, and surgery and supportive
reatment are complicated and often not accessible for victims in
eveloping countries (Malhi and Gores, 2006). The risk factors for
CA in areas where liver flukes are not endemic in Thailand include
rimary sclerosing cholangitis, hepatolithiasis, and choledochal
ysts (Sripa and Pairojkul, 2008). These factors share long-standing
nflammation and chronic injury of the biliary epithelium as a com-
on  determinant.
.3. A putative pathogenicity factor – granulin, a mitogen from O.
iverrini
The mechanisms by which chronic infection with O. viverrini
esults in cholangiocarcinogenesis are presumed to multi-factorial
Sripa and Pairojkul, 2008), but one such mechanism is the secre-
ion of parasite proteins with mitogenic properties into the bile
ucts, driving cell proliferation and creating a tumorigenic environ-
ent (Sripa et al., 2007; Smout et al., 2009). Recently, a proteomic
pproach identified an orthologue of human granulin, a potent
rowth factor involved in cell proliferation and would healing, in
he excretory/secretory (ES) products of the parasite (Smout et
l., 2009). O. viverrini granulin, termed Ov-GRN-1, was expressed
n most parasite tissues, particularly the gut and tegument. Fur-
hermore, Ov-GRN-1 was detected in situ on the surface of biliary
pithelial cells of hamsters experimentally infected with O. viver-
ini. Recombinant Ov-GRN-1 was expressed in Escherichia coli and
efolded from inclusion bodies. Refolded protein stimulated pro-
iferation of murine fibroblasts at nanomolar concentrations and
nduced shape changes in affected cells. Antibodies raised to recom-
inant Ov-GRN-1 inhibited the ability of O. viverrini ES products to3.2 6 Nephritis and nephrosis
2.9 5 Traffic accidents
2.5 4 Cervix uteri cancer
induce proliferation of murine fibroblasts and a human cholangio-
carcinoma cell line in vitro, indicating that Ov-GRN-1 is the major
growth factor present in O. viverrini ES products. The report of
a secreted growth factor from a parasitic helminth that induces
proliferation of host cells supports a role for this fluke protein in
establishment of a tumorigenic environment that may  ultimately
manifest as cholangiocarcinoma.
6. Epidemiology of liver fluke-induced bile duct cancer
O. viverrini is one of only three metazoan pathogens classi-
fied as Group 1 carcinogens by the World Health Organization’s
International Agency for Research on Cancer (the other two being
C. sinensis and Schistosoma haematobium)  (Bouvard et al., 2009).
Epidemiological studies have determined that the incidence of
cholangiocarcinoma (CCA) correlates strongly with the prevalence
of O. viverrini infection (Parkin et al., 1993; Jongsuksuntigul and
Imsomboon, 2003; Parkin, 2006; Shin et al., 2010). CCA is the pre-
dominant type of liver cancer in Thailand (Sripa and Pairojkul,
2008). Fig. 3 shows that the incidence of CCA in the four major
regions of Thailand varies by at least 12-fold and has a strong
positive correlation with the prevalence of O. viverrini infection
(Sripa et al., 2007). For example, in adult males, there is an 8.5-
fold increase in CCA incidence in the upper Northeast Province of
Nakhon Phanom (85.5%) over the Southern province of Prachuap
Khiri Khan (10.0%) (Sripa et al., 2007). This difference is an exam-
ple of the marked regional variation of liver cancer deaths, with
the highest mortality rate (per 100,000) in Northeast provinces,
which harbors 9 out of the top 10 provinces with highest num-
ber of liver cancer deaths in Thailand (Sripa and Pairojkul, 2008).
Few data on CCA incidence in Lao PDR have been reported (Shin
et al., 2010). However, suspected CCA diagnosed by ultrasonogra-
phy has been observed in ∼5% of people in villages endemic for
opisthorchiasis in the Lao PDR (S. Phompida, personal communica-
tion). A disproportionate number of deaths occur in male heads of
households, who often are the family’s primary wage earner. There-
fore, opisthorchiasis and CCA also exert a heavy economic toll that
in Thailand costs at least $120 million annually in both medical care
and lost wages (Andrews et al., 2008). Typically O. viverrini infec-
tion begins in childhood, residents harbor chronic infections and,
after three to four decades, liver cancer is diagnosed in a subset of
individuals, with males affected more than females. CCA has a poor
prognosis; death is swift, usually occurring within 3–6 months of
diagnosis (Andrews et al., 2008). In northern Thailand, an estimated
5000 cases of CCA are diagnosed annually (Parkin, 2006), which
translates into 5000 deaths superimposed on a chronic burden of
liver and bile duct disease (Table 2).In the human bile ducts, chronic O. viverrini infection results
in a chronic inflammatory state that leads to severe hepatobil-
iary abnormalities. The cumulative damage caused by this chronic
inflammation can lead to advanced, pathogen-specific disease
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CFig. 3. O. viverrini infection in Thailand in relationship
equelae including obstructive jaundice, hepatomegaly, cholecysti-
is, and CCA. Moreover, aside from these obvious signs of morbidity
n opisthorchiasis, important inflammatory changes to the liver
an occur early in the course of the disease (Mairiang et al., 1992,
006; Sripa et al., 2009), most of which will remain clinically silent
nless actively detected by ultrasound or other imaging modali-
ies (Mairiang et al., 2006). Community-based ultrasound studies
n O. viverrini endemic areas of Northeastern Thailand suggest that
epatobiliary abnormalities such as enlargement of the left hepatic
obe and the gallbladder, loss of gallbladder contractility, presence
f sludge, and increased periductal fibrosis are common (Elkins
t al., 1990, 1996; Mairiang et al., 1992, 2006; Sripa et al., 2009).
ue to the high prevalence of O. viverrini infection in East Asia,
hich can be as high 60–70% in populations resident in endemic
reas (Sithithaworn and Haswell-Elkins, 2003; Sripa and Pairojkul,
008) asymptomatic hepatobiliary abnormalities may  represent
he greatest part of the disease burden associated with opisthorchi-
sis.
Overall, approximately one-quarter of people with O. viverrini
nfection develop periductal fibrosis (Sripa et al., 2007), and many
ill develop CCA (Parkin, 2006; Sripa et al., 2007; Shin et al., 2010).
tudies conducted in Khon Kaen Province, the most populated area
f northeastern Thailand, reveal a bleak picture of hyperendemicity
f O. viverrini infection that results in an alarming death rate from
CA (Sripa and Pairojkul, 2008). Here, the prevalence of O. viverrinie incidence of cholangiocarcinoma (CCA) by province.
infection focally reaches 70% or higher in villages along the Chi River
Basin. The incidence of CCA in this province may be the highest in
the world, with an age-standardized incidence rate (ASR) of 78.4
per 100,000 in males and 33.3 in females. As noted, the treatment
of choice for opisthorchiasis is oral administration of praziquantel.
Anthelmintic treatment with praziquantel will not reliably reverse
periductal fibrosis and inflammation (Mairiang et al., 1993) and,
therefore, may  not prevent the onset of cholangiocarcinoma.
7. Sustainable control of opisthorchiasis: lessons from
Thailand
7.1. History of opisthorchiasis control
Opisthorchiasis control in Thailand began more than 50 years
ago (Table S1). During 1950–1958, with support from USAID, the
Thai Department of Health established Helminthiasis Control Units
in five provinces – Nakorn Ratchasima, Udon Thani, Sakon Nakon,
Ubon Ratchathani and Songkhla (Jongsuksuntigul and Imsomboon,
2003). Services provided by the units included diagnosis and treat-
ment of intestinal parasites, including liver fluke. At the conclusion
of USAID support, the Helminthiasis Control Units were dissolved
and control activities integrated into the Rural Health Develop-
ment Project. From 1967 to 1974, an Opisthorchiasis Control Unit
was  established in Sakol Nakorn province, Northeast Thailand, as
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art of the Rural Health Development Project. The activities of
he Opisthorchiasis Control Unit focused on community health
ducation, utilizing a variety of control strategies including demon-
trations of how to properly cook fish and the distribution of low
ost cooking pots. After the introduction of the anthelmintic praz-
quantel in Thailand in the early 1980s, a joint field trial organized
y Mahidol University and the Helminthiasis Section of the Depart-
ent of Communicable Disease Control, Ministry of Public Health
as conducted in Northeast Thailand. From 1980 to 1983, this field
rial demonstrated that the cure rate for liver fluke of a single dose
raziquantel, 40 mg/kg was as high as 96% (Jongsuksuntigul and
msomboon, 2003). During 1984–1987, the Department of Commu-
icable Disease Control organized four opisthorchiasis treatment
nits in Khon Kaen, Roi-Et, Sakol Nakorn and Ubon Ratchathani
rovinces in Northeast Thailand. The units undertook stool exams
f ∼630,000 residents, and treatment for 400,452 cases.
Development of opisthorchiasis control operations on a region-
ide scale began in 1987, when an opisthorchiasis control program
as included in the Sixth Five-year National Public Health Devel-
pment Plan (1987–1991) under the auspices of the Department
f Communicable Disease Control. During that period, ∼5.3 mil-
ion stool samples were examined, with ∼1.8 million positive
ases treated. During 1989–1992 the Federal Republic of Germany
rovided technical and operational support for the Promotion
f Community Health through Parasite Control Project in seven
ortheastern provinces, covering approximately 3 million people;
,839,813 individuals received stool exams, with 531,175 positive
ases treated. In the Seventh National Health Development Plan
1992–1996), the plan was extended to an additional 17 provinces
n Northern Thailand and 6 Central region provinces. Currently,
ontrol activities for opisthorchiasis have been integrated into
 comprehensive rural health service that targets all provinces.
ccording to the 8th National Health Plan (1997–2001), the
pisthorchiasis control program was integrated into the Nation-
ide Disease Control Aims, with the objective of reducing the
revalence of O. viverrini infection to <10%. Many campaigns against
he consumption of “raw fish” have been organized by differ-
nt governmental agencies and non-governmental organizations
NGOs). This extensive National Opisthorchiasis Control Program
as resulted in marked reductions in level of O. viverrini infection,
ith the national prevalence falling from 63.6% (1984–1987) to
.6% in 2001 (Jongsuksuntigul and Imsomboon, 2003).
After 2000, the National Opisthorchiasis Control Program activ-
ties subsided due to the Asian economic crisis, which forced a
eduction in government funding and diversion of resources to
ther priorities. Recent data from the National Helminthic Survey
howed that the prevalence of O. viverrini was 8.7%, with the highest
revalence in the Northeast (16.6%), followed by the North (10.0%),
he Central (1.3%) and the Southern (0.1%) regions (T. Wongsaroj,
npublished). The target prevalence for liver fluke infection pro-
ected by the Department of Disease Control, Ministry of Public
ealth, Thailand is 5% by the year 2016. The prevalence of O. viver-
ini infection at national level during 1984 to 2009 is shown in
igure S1.
.2. Strategic approaches for liver fluke control
Although the prevalence of O. viverrini has declined at the
ational level, it remains high in Northeast Thailand (16.6% in 2009
s. 15.8% in 2001), with a correspondingly high incidence of CCA
Sripa and Pairojkul, 2008). Therefore, there is a pressing need to
aintain an effective control program. However, due to budgetarynd health policy constraints (Sripa, 2008), integrated strategic
pproaches should be targeted in high endemic areas in Northeast
nd North Thailand. The idea here is similar to what has been suc-
essfully done before in Thailand (Jongsuksuntigul and Imsomboon,0S (2011) S158– S168 S165
2003), but this time with a more systematic and focused approach.
Figure S2 presents our suggestions for a systematic and focused
approach to opisthorchiasis control in Northeastern Thailand. We
have divided “control” into four elements: (1) modifications to cur-
rent control measures; (2) the subsequent behavioral changes in
the population; (3) the public health impact of these behavioral
changes, and (4) the epidemiological impact, which would be a
decline in the prevalence of O. viverrini infection and in the future
a decline in the incidence of CCA. We  suggest that simple modifi-
cation to current control policies can result in a marked decrease
in the prevalence of O. viverrini infection and subsequently the
incidence of CCA. For example, the use of mobile stool exami-
nation teams, equipped to treat positive cases could increase the
frequency (yearly) and the geographic range of fecal exams, result-
ing in a reduction in the host reservoir (humans) and possibly a
decline in transmission to reservoir hosts, e.g. cats. These activities
should be carried out several consecutive years with >60% coverage
for each round. Whenever the situation of the prevalence in any
area falls below 10%, the active services then gradually switch to
passive services (Jongsuksuntigul and Imsomboon, 2003). Another
modification to current health practices would be strengthening
the health education aspects, aiming to reduce consumption of
uncooked fish to reduce infection/re-infection intensity. Public
health promotion including information, education and communi-
cation (IEC) devices should emphasize the need to modify personal
hygiene (defecation) behavior, specifically the use of latrines, to
reduce environmental contamination with O. viverrini eggs. We
consider modifications to current practices would result in sub-
stantial decreases in the prevalence of O. viverrini infection, which
would eventually be followed by a decrease the incidence of CCA.
To achieve the goal, multisectoral partnerships such as government
(Ministry of Public Health, Ministry of Education, Ministry of Sci-
ences and Technology, Ministry of Agriculture), granting agencies,
and private sectors, including NGOs must be orchestrated in the
plan. This would start with modifications to government health pol-
icy, which should prioritize liver fluke as a national health problem
as in previous campaigns. The support would include increasing
the infrastructure for the diagnosis and surveillance of O. viverrini
infection, as well as a national “anti-liver fluke” campaign, with
concomitant health education.
8. Role for a vaccine?
From a public health perspective, thorough cooking of the
cyprinoid fish efficiently blocks infection with these parasites. In
this regard, liver fluke-associated CCA is preventable by changes
in eating habits. Unfortunately, age-old culinary preferences for
uncooked dishes such as koi-pla (Fig. 1) do not readily allow for
this possibility. Moreover, fish farming of grass carp and other
susceptible species in ponds that are routinely contaminated by
untreated sewage has resulted in the establishment of infection
in fish populations at large, which, along with the involvement of
animal reservoir hosts, makes control of liver fluke infection even
more challenging (Lun et al., 2005; Sripa et al., 2007). Nonethe-
less, given this extraordinary linkage between a metazoan parasite
and a tumour, characterization of the nature and action of carcino-
gens of O. viverrini or C. sinensis may  provide fundamental insights
into carcinogenesis at large. Moreover, our previous work points to
the feasibility of developing an opisthorchiasis vaccine. Based on a
gene discovery project for adult stage O. viverrini, we have predicted
more than 5000 protein encoding genes (Laha et al., 2007; Young et
al., 2010). Among these, we  characterized a subset with predicted
functions at the host–parasite interface, specifically protein likely
to be secreted or to be membrane associated in the adult fluke, and
thereby likely to be in direct contact with the epithelial cells of the
S166 B. Sripa et al. / Acta Tropica 120S (2011) S158– S168
Fig. 4. Immunolocalization of cathepsin F cysteine protease (Ov-CF-1) in O. viverrini infected hamster liver. Thin sections of paraffin embedded liver tissues were probed
with  rabbit antiserum (Panel A) Representative section of liver from an uninfected hamster, spanning a portal triad including a secondary bile duct, probed with rabbit
anti-Ov-CF-1serum (negative control). Infected hamster liver in the vicinity of the secondary bile ducts too small in internal diameter to include an adult fluke, probed with
t ndica
K ult O. 
g idase
i
C
O
p
a
a
t
r
a
D
o
t
v
t
c
A
U
D
d
N
A
t
R
Ahe  rabbit anti-Ov-CF-1 serum (Panels B and C). Immunoperoxidase stain (brown) i
upffer and mononuclear cells (Panel C). Section through bile duct containing an ad
ut),  and to the epithelial cells lining the infected bile duct (Panel D). Immunoperox
nfected bile ducts, e.g. Pinlaor et al. (2009),  Smout et al. (2009).
haracterization of the nature and action of secreted proteins of
. viverrini such as cathepsin F (Pinlaor et al., 2009) (Fig. 4) may
rovide insights into liver fluke-induced cholangiocarcinogenesis,
nd indeed fundamental insights into carcinogenesis at large. In
ddition, fluke proteins at the host–parasite interface have poten-
ial as intervention targets including as vaccine candidates, given
ecent successes with chemotherapy targeting proteolytic enzymes
nd tetraspanins in schistosomes and liver flukes (McManus and
alton, 2006; Tran et al., 2006; Abdulla et al., 2007). Indeed, in view
f the acclaimed vaccine against papilloma-virus infection that pro-
ects against cervical cancer (Schiller et al., 2008), it is feasible that
accination to prevent O. viverrini infection could provide protec-
ion against another infection-related cancer, liver fluke-induced
holangiocarcinoma.
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